Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.

NCT01876459 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
265
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Strasbourg, France